These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27681573)

  • 1. Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina.
    Morales-López SE; Taverna CG; Bosco-Borgeat ME; Maldonado I; Vivot W; Szusz W; Garcia-Effron G; Córdoba SB
    Mycopathologia; 2016 Dec; 181(11-12):871-878. PubMed ID: 27681573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
    Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
    J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
    Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
    J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.
    Tay ST; Lotfalikhani A; Sabet NS; Ponnampalavanar S; Sulaiman S; Na SL; Ng KP
    Mycopathologia; 2014 Oct; 178(3-4):307-14. PubMed ID: 25022264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata.
    Dhieb C; Normand AC; Al-Yasiri M; Chaker E; El Euch D; Vranckx K; Hendrickx M; Sadfi N; Piarroux R; Ranque S
    Med Mycol; 2015 Jun; 53(5):462-9. PubMed ID: 25841053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.
    Morales-López S; Dudiuk C; Vivot W; Szusz W; Córdoba SB; Garcia-Effron G
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
    Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
    Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Antifungal Susceptibility of Candida nivariensis from Vulvovaginal Candidiasis.
    Shi Y; Zhu Y; Fan S; Vitagliano A; Liu X; Liao Y; Liang Y; Vitale SG
    Gynecol Obstet Invest; 2020; 85(1):88-93. PubMed ID: 31694024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Antifungal Susceptibility Profiles of
    Hou X; Xiao M; Chen SC; Wang H; Yu SY; Fan X; Kong F; Xu YC
    Front Microbiol; 2017; 8():5. PubMed ID: 28154553
    [No Abstract]   [Full Text] [Related]  

  • 11. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of human pathogens of the clade Nakaseomyces in a culture collection-the first report on Candida bracarensis in Poland.
    Małek M; Mrowiec P; Klesiewicz K; Skiba-Kurek I; Szczepański A; Białecka J; Żak I; Bogusz B; Kędzierska J; Budak A; Karczewska E
    Folia Microbiol (Praha); 2019 May; 64(3):307-312. PubMed ID: 30361876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay.
    Vatanshenassan M; Arastehfar A; Boekhout T; Berman J; Lass-Flörl C; Sparbier K; Kostrzewa M
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Candida glabrata complex species: use of Vitek MS
    Hou X; Xiao M; Chen SC; Kong F; Wang H; Fan X; Zhao YP; Xu YC
    Future Microbiol; 2018 May; 13():645-657. PubMed ID: 29745727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Isolation of Candida nivariensis, an Emerging Fungal Pathogen, in Kuwait.
    Alobaid K; Asadzadeh M; Bafna R; Ahmad S
    Med Princ Pract; 2021; 30(1):80-84. PubMed ID: 32927454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait.
    Asadzadeh M; Alanazi AF; Ahmad S; Al-Sweih N; Khan Z
    PLoS One; 2019; 14(10):e0223920. PubMed ID: 31618264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.
    Borman AM; Petch R; Linton CJ; Palmer MD; Bridge PD; Johnson EM
    J Clin Microbiol; 2008 Mar; 46(3):933-8. PubMed ID: 18199788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caenorhabditis elegans as a Model System To Assess Candida glabrata,
    Hernando-Ortiz A; Mateo E; Ortega-Riveros M; De-la-Pinta I; Quindós G; Eraso E
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32718968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies.
    Gil-Alonso S; Jauregizar N; Cantón E; Eraso E; Quindós G
    Antimicrob Agents Chemother; 2015; 59(6):3615-8. PubMed ID: 25801575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.